Assembly Biosciences, Inc. Liabilities, Noncurrent
Assembly Biosciences, Inc. (ASMB) had Liabilities, Noncurrent of $38.92 million as of 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2019-02-28
- 2018-12-31: Liabilities, Noncurrent $38.92M.
- 2018-09-30: Liabilities, Noncurrent $38.93M.
- 2018-06-30: Liabilities, Noncurrent $40.19M.
- 2018-03-31: Liabilities, Noncurrent $41.46M.
| Period end | Liabilities, Noncurrent | Liabilities, Noncurrent as first filed |
|---|---|---|
| 2018-12-31 | $38.92M 10-K · filed 2019-02-28 | |
| 2018-09-30 | $38.93M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $40.19M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $41.46M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $42.69M 10-K · filed 2019-02-28 | $42.69M 10-K · filed 2018-03-08 |
| 2017-09-30 | $52.96M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $54.25M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $55.44M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $11.12M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $11.60M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $11.60M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $11.60M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $11.60M 10-K · filed 2017-03-02 | |
| 2015-09-30 | $11.60M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $11.60M 10-Q · filed 2015-08-13 | |
| 2014-12-31 | $11.60M 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |